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In both developed and developing countries, the need
for evidence-based decision-making in immunization
programs has become crucial in light of multiple health
priorities, limited human resources and logistical capaci-
ties, as well as the high cost of vaccines relative to lim-
ited public funds that are available. An important step
that countries can take to encourage well-informed deci-
sion-making is to establish a group of national experts
to advise the policy makers at the Ministry of Health
and program managers for making decisions, including
choices of new vaccines and needed adjustments to
existing programs and schedules.
So far, many countries have already constituted such
National Immunization Technical Advisory Groups
(NITAGs) while other countries are currently working
towards their establishment with the support of technical
partners such as WHO and AMP (SIVAC Initiative).
Based on WHO recommendations, the composition of the
advisory group should include two categories of members:
core and non-core members. All core members should be
independent and credible experts who serve in their own
capacity and who do not represent the interests of a parti-
cular group. Core members only, should participate in
advising and deciding on the final set of recommendations.
Non-core members hold key positions with important
government entities they represent (e.g. Outbreaks Surveil-
lance Department, National Drugs Regulatory Authorities,
National Public Health Laboratory etc.) and represent
various important professional societies, and key technical
partners (e.g. WHO and UNICEF).
It is recommended that the committee be multidisci-
plinary and represent a broad range of expertise from
the following disciplines: clinical medicine (pediatrics
medicine, adult medicine, geriatrics), epidemiologists,
infectious diseases specialists, microbiologists, public
health, immunology, vaccinology. Pasteur Institutes have
a crucial role to play in the NITAGs’ activities. They
can either be sought to participate as non-core member
or to send experts as core members.
As non-core member, Pasteur Institutes provide data
regarding burden of disease related to their laboratory
surveillance activities. They will also provide specific
information regarding immunology and safety issues
related to vaccines. They can also provide information
regarding emerging diseases and therefore influence the
national research agenda by having the NITAG issuing
specific recommendations. As core members, the experts
from Pasteur Institutes should refrain from promoting
the policies and views and products of the organization
but this leads to an indirect recognition of the expertise
of the institution.
As shown in other countries, it also may conduct to
NITAG formal request regarding surveys and studies
related to vaccines to the institution. Among other
countries, the SIVAC Initiative is currently supporting
Cote d’Ivoire and Viet Nam in establishing and
strengthening NITAGs. In both countries, Pasteur Insti-
tutes already participate actively to the process and
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